You may have heard about the Gardasil vaccine, but you may not have heard about the serious side effects, allegedly affecting some young women. Merck, the company that manufactures the vaccine, the CDC and the FDA all say Gardasil is safe, effective, and important. Join Law.com bloggers and co-hosts, J. Craig Williams and Bob Ambrogi, who will discuss this controversy and the litigation swirling around Gardasil with experts, Attorney Tom Girardi, nationally known plaintiff lawyer from the California firm, Girardi & Keese and Erin Brockovich, (yes the real Erin Brockovich from the movie by the same name), President of Brockovich Research & Consulting. They will take a look at the side effects in some cases, Gardasil litigation and focus in on the efforts to educate young women about this controversial vaccine.
Recently a federal jury ruled in favor of Merck & Co. Inc. in a lawsuit over the painkiller Vioxx, finding there was not enough evidence to link the drug to a Kentucky man’s heart attack. In this show, we will speak with a key attorney on the team representing Merck in the Vioxx cases. On past Coast to Coast shows, we have had lead attorneys for the plaintiffs affected by Vioxx as guests- this time around we will get Merck’s angle. Join co-hosts and Law.com bloggers, J. Craig Williams and Robert Ambrogi as they discuss Merck’s perspective with Attorney Phillip Beck, partner with the firm of Bartlit Beck Herman Palenchar & Scott LLP in Chicago. Don’t miss out on this highly anticipated show!
As jury selection gets underway in the 2nd Federal Vioxx trial in New Orleans, there are more than 13-thousand other cases filed against Merck. Where do they stand? Join Ringler Radio host, Larry Cohen and co-host, Ringler Associates Chairman, Dennis English with special guest, Attorney Ted Meadows from one of the largest firms in the nation, Beasley Allen, representing a large number of Vioxx plaintiffs. Get the latest details on Vioxx lawsuits and hear the discussion about Vioxx plaintiffs, the Vioxx trial outcomes to date and Merck’s strategy to defend one of the biggest actions against a pharmaceutical in history.
On this edition of Coast to Coast, find out more about personal injury lawsuits and class actions being filed against Merck by women who took the drug, Fosamax. Many now suffer severe medical and dental problems. Co-hosts & Attorneys J. Craig Williams and Robert Ambrogi explore what’s going on with Fosamax with the lawyer taking the lead nationwide in Fosamax litigation – Attorney Tim O’Brien at the firm of Levin, Papantonio,Thomas, Mitchell, Ecshner & Proctor in Pensacola.
Coast to Coast, with J. Craig Williams and Robert Ambrogi, takes a hard look at the future for VIOXX litigation nationwide, particularly after the recent win for Merck Pharmaceuticals in the New Jersey trial. Very special guests in our discussion are nationally recognized Attorney Tom Girardi of the L-A firm of Girardi-Keese known for taking on goliaths in the past, Attorney Dawn Barrios of the Louisiana firm, Barrios, Kingsdorf & Casteix – both of whom serve on the Liason Committee for MDL-1657 for VIOXX product liability litigation – and NJ Law Journal reporter, Lisa Brennan who covered the recent NJ VIOXX trial and has spoken to jurors and the lawyers on both sides since the verdict. You can’t miss the opportunity to hear this discussion!
Coast to Coast, with Robert Ambrogi and J. Craig Williams from Law.com’s arsenal of law bloggers gets first hand accounts from inside the courtroom at the VIOXX trial underway in New Jersey. A 60-yr old war veteran claims VIOXX caused his heart attack. Special guest, Attorney Sam Davis, from Davis, Saperstein & Solomon, P.C., who has been attending the trial to gather information for his own plaintiffs’ cases against Merck Pharmaceuticals, recounts developments in the trial including some outbursts between Merck lead defense counsel and Judge Carol Higbee. Also joining us on the show is NJ Law Journal reporter Lisa Brennan and well-known defense Attorney Alan Klein from Duane Morris LLP, who was MDL liason counsel for a pharmaceutical manufacturer in the diet drug fen-phen litigation. Three important perspectives you won’t want to miss!